This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mohamadzadeh, M. Articles by Schmaljohn, A. L. Search for Related Content PubMed PubMed Citation Articles by Mohamadzadeh, M. Articles by Schmaljohn, A. L.

Activation of Triggering Receptor Expressed on Myeloid Cells-1 on Human Neutrophils by Marburg and Ebola Viruses

U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland,¹ National Cancer Institute, Frederick, Maryland²

Received 15 March 2006/ Accepted 21 April 2006

Marburg virus (MARV) and Ebola virus (EBOV), members of the viral family Filoviridae, cause fatal hemorrhagic fevers in humans and nonhuman primates. High viral burden is coincident with inadequate adaptive immune responses and robust inflammatory responses, and virus-mediated dysregulation of early host defenses has been proposed. Recently, a novel class of innate receptors called the triggering receptors expressed in myeloid cells (TREM) has been discovered and shown to play an important role in innate inflammatory responses and sepsis. Here, we report that MARV and EBOV activate TREM-1 on human neutrophils, resulting in DAP12 phosphorylation, TREM-1 shedding, mobilization of intracellular calcium, secretion of proinflammatory cytokines, and phenotypic changes. A peptide specific to TREM-1 diminished the release of tumor necrosis factor alpha by filovirus-activated human neutrophils in vitro, and a soluble recombinant TREM-1 competitively inhibited the loss of cell surface TREM-1 that otherwise occurred on neutrophils exposed to filoviruses. These data imply direct activation of TREM-1 by filoviruses and also indicate that neutrophils may play a prominent role in the immune and inflammatory responses to filovirus infections.

This article has been cited by other articles:

• Ho, C.-C., Liao, W.-Y., Wang, C.-Y., Lu, Y.-H., Huang, H.-Y., Chen, H.-Y., Chan, W.-K., Chen, H.-W., Yang, P.-C. (2008). TREM-1 Expression in Tumor-associated Macrophages and Clinical Outcome in Lung Cancer. Am. J. Respir. Crit. Care Med. 177: 763-770 [Abstract] [Full Text]  
• Dower, K., Ellis, D. K., Saraf, K., Jelinsky, S. A., Lin, L.-L. (2008). Innate Immune Responses to TREM-1 Activation: Overlap, Divergence, and Positive and Negative Cross-Talk with Bacterial Lipopolysaccharide. J. Immunol. 180: 3520-3534 [Abstract] [Full Text]  
• Klesney-Tait, J., Colonna, M. (2007). Uncovering the TREM-1-TLR connection. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1374-L1376 [Full Text]  
• Gomez-Pina, V., Soares-Schanoski, A., Rodriguez-Rojas, A., del Fresno, C., Garcia, F., Vallejo-Cremades, M. T., Fernandez-Ruiz, I., Arnalich, F., Fuentes-Prior, P., Lopez-Collazo, E. (2007). Metalloproteinases Shed TREM-1 Ectodomain from Lipopolysaccharide-Stimulated Human Monocytes. J. Immunol. 179: 4065-4073 [Abstract] [Full Text]  
• Haselmayer, P., Grosse-Hovest, L., von Landenberg, P., Schild, H., Radsak, M. P. (2007). TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 110: 1029-1035 [Abstract] [Full Text]